{
    "clinical_study": {
        "@rank": "31997", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if it is safe and effective to give adefovir (a new\n      anti-HIV drug) plus nelfinavir to HIV-infected children who are already receiving other\n      anti-HIV medications."
        }, 
        "brief_title": "Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "During the first phase of the study (Days 1-6), the safety and tolerability of multiple\n      doses of ADF is assessed when administered simultaneously with the patient's reverse\n      transcriptase inhibitor (RTI) regimen. The second phase begins on Day 7 when nelfinavir is\n      added to the therapy regimen for an additional 15 weeks. ADF pharmacokinetics are measured\n      on Days 1,  2, and 7 (on a subset of 18 patients); peak and trough samples are collected on\n      Day 28."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Your child may be eligible for this study if he/she:\n\n          -  Is 3 months to 16 years old.\n\n          -  Is HIV-positive.\n\n          -  Has never taken protease inhibitors or has previously taken ritonavir (RTV),\n             saquinavir (SQV), or indinavir (IDV) and is willing to stop the medication at study\n             entry.\n\n          -  Is taking an anti-HIV drug combination that will not change during at least the 2\n             weeks prior to study entry.\n\n          -  Agrees to use effective barrier methods of birth control, such as condoms, during the\n             study.\n\n          -  Has consent of parent or guardian.\n\n        Exclusion Criteria\n\n        Your child will not be eligible for this study if he/she:\n\n          -  Has ever taken NFV.\n\n          -  Has a history of opportunistic (AIDS-related) infection.\n\n          -  Has any disease or illness that would prevent him/her from completing the study,\n             including cancer.\n\n          -  Has taken certain medications, including protease inhibitors at study entry.\n\n          -  Is receiving an HIV vaccine at study entry.\n\n          -  Is pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "16 Years", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": "36", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002219", 
            "org_study_id": "232H", 
            "secondary_id": "GS-97-418"
        }, 
        "intervention": [
            {
                "intervention_name": "Nelfinavir mesylate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Levocarnitine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Adefovir dipivoxil", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Carnitine", 
                "Adefovir", 
                "Adefovir dipivoxil", 
                "Nelfinavir", 
                "HIV Protease Inhibitors"
            ]
        }, 
        "keyword": [
            "Dose-Response Relationship, Drug", 
            "Antiviral Agents", 
            "HIV Protease Inhibitors", 
            "Disease Progression", 
            "RNA, Viral", 
            "Adenine", 
            "Viral Load", 
            "Age Factors", 
            "Nelfinavir"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33731"
                    }, 
                    "name": "All Children's Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane Univ Med Ctr / Dept of Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10457"
                    }, 
                    "name": "Bronx Lebanon Hosp Ctr / Dept of Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11021"
                    }, 
                    "name": "North Shore Univ Hosp / Division of Immunology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10025"
                    }, 
                    "name": "St Lukes Roosevelt Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke Univ Med Ctr / Duke South Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Med Univ of South Carolina"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase I/II, Open-Label, Multi-Center Study of the Pharmacokinetics, Safety, Tolerance and Activity of Two Dose Levels of Adefovir Dipivoxil (ADF) and Nelfinavir When Added to Antiretroviral Therapy for the Treatment of HIV-Infected Pediatric Patients", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002219"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 1999"
    }, 
    "geocoordinates": {
        "All Children's Hosp": "27.773 -82.64", 
        "Bronx Lebanon Hosp Ctr / Dept of Pediatrics": "40.85 -73.867", 
        "Duke Univ Med Ctr / Duke South Hosp": "35.994 -78.899", 
        "Med Univ of South Carolina": "32.777 -79.931", 
        "North Shore Univ Hosp / Division of Immunology": "40.801 -73.728", 
        "St Lukes Roosevelt Hosp Ctr": "40.714 -74.006", 
        "Tulane Univ Med Ctr / Dept of Pediatrics": "29.951 -90.072"
    }
}